chloroquine has been researched along with amphotericin b in 96 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (7.29) | 18.7374 |
1990's | 4 (4.17) | 18.2507 |
2000's | 37 (38.54) | 29.6817 |
2010's | 45 (46.88) | 24.3611 |
2020's | 3 (3.13) | 2.80 |
Authors | Studies |
---|---|
Adsersen, A; Christensen, SB; Nielsen, C; Nyman, U; Olsen, CE; Pushpangadan, P; Sittie, A; Smitt, UW; Valsaraj, R | 1 |
Berecibar, A; Davioud-Charvet, E; Debreu, MA; Girault, S; Grellier, P; Lemière, P; Maes, L; Mouray, E; Sergheraert, C | 1 |
Clark, AM; Dunbar, DC; Muhammad, I; Takamatsu, S; Walker, LA | 1 |
Dunbar, DC; ElSohly, MA; Khan, IA; Li, XC; Muhammad, I | 1 |
Bagherzadeh, K; Budnik, BA; Christensen, J; Jaroszewski, JW; Kharazmi, A; Sairafianpour, M; Staerk, D | 1 |
Asfa, M; Christensen, J; Jaroszewski, JW; Kayser, O; Sairafianpour, M; Staerk, D; Witt, M | 1 |
Dunbar, DC; Ferreira, D; Jacob, MR; Li, XC; Muhammad, I; Tekwani, BL | 1 |
Hamann, MT; Mesecar, AD; Rao, KV; Santarsiero, BD; Schinazi, RF; Tekwani, BL | 1 |
Bedir, E; Dunbar, DC; Ferreira, D; Khan, SI; Muhammad, I; Takamatsu, S; Tekwani, BL; Walker, LA | 1 |
Avery, MA; Bandyopadhyaya, AK; Desai, PV; Furtado, MM; Muraleedharan, KM; Tekwani, BL | 1 |
Bedir, E; Khan, IA; Khan, SI; Muhammad, I; Pelletier, J; Takamatsu, S; Tekwani, BL; Walker, LA | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
Avery, M; Desai, PV; Gut, J; Patny, A; Rosenthal, P; Sabnis, Y; Srivastava, A; Tekwani, B | 1 |
Khan, SI; Sneden, AT; Tekwani, BL; Thiem, DA | 1 |
Acebey, L; Bonduelle, C; Duigou, AG; Jullian, V; Prévost, MF; Sauvain, M; Valentin, A | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Bharate, SB; Chauthe, SK; Jacob, MR; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL; Yunus, NA | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Patel, SR; Patil, P; Tekwani, BL | 1 |
Ablordeppey, SY; Fan, P; Jacob, M; Khan, A; Khan, S; Li, S; Mardenborough, LG; Walker, L; Zhang, W; Zhu, XY | 1 |
Beauchene, J; Caffrey, CR; Cohen, FE; Debnath, A; Doyle, PS; Fafarman, AT; Fairlamb, AH; Kelly, B; Land, KM; May, BC; McKerrow, JH; Moll, H; Ponte-Sucre, A; Saravanamuthu, A; Schirmeister, T; Schreiber, K; Steverding, D; Swenerton, RK; Walshe, D; Weisman, JL; Zhou, YM; Zorn, JA | 1 |
Borne, RF; Khan, MO; Levi, MS; Tekwani, BL; Wilson, NH | 1 |
Farasati, NA; Huang, Y; Randhawa, P | 1 |
Bharate, SB; Jacob, M; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL | 1 |
Azas, N; Ducros, C; Gasquet, M; Hutter, S; Laget, M; Rathelot, P; Rault, S; Vanelle, P; Verhaeghe, P | 1 |
Doerksen, RJ; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Prasanna, S; Shilabin, AG | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Tekwani, BL | 1 |
Engene, N; Gerwick, L; Gerwick, WH; Ortega-Barría, E; Romero, LI; Simmons, TL; Ureña, LD | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Coley, PD; Cubilla-Rios, L; Della-Togna, G; Gerwick, WH; Kursar, TA; Martínez-Luis, S | 1 |
Alley, MC; ElSohly, MA; Feng, S; Galal, AM; Gul, W; Hollingshead, MG; Kaur, G; Ross, SA; Slade, D | 1 |
Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA | 1 |
Almanza, A; Clark, BR; Gerwick, WH; Kyle, DE; Linington, RG; Trimble, EE; Ureña, LD | 1 |
Ahmed, SA; Elsohly, MA; Khan, IA; Radwan, MM; Ross, SA; Slade, D | 1 |
Azas, N; Castera-Ducros, C; Dumètre, A; Gasquet, M; Hutter, S; Laget, M; Rathelot, P; Rault, S; Reboul, JP; Vanelle, P; Verhaeghe, P | 1 |
Azas, N; Casano, G; Darque, A; Dumètre, A; Hutter, S; Pannecouque, C; Robin, M | 1 |
Hamann, MT; Kudrimoti, S; Peng, J; Tekwani, BL; Wahba, AE | 1 |
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL | 1 |
Benicewicz, DB; Chen, PC; Gryder, B; Guerrant, W; Khan, SI; Oyelere, AK; Patil, V; Tekwani, BL | 1 |
Azas, N; Combes, S; Delmas, F; Dumètre, A; Finet, JP; Hutter, S; Laget, M; Pierson, JT | 1 |
Azas, N; Dumètre, A; Gellis, A; Hutter, S; Kabri, Y; Laget, M; Vanelle, P; Verhaeghe, P | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B | 1 |
Balunas, MJ; Fenner, AM; Gerwick, WH; Kyle, DE; Linington, RG; Tidgewell, K; Togna, GD; Ureña, LD | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Della Togna, G; Gerwick, WH; Kyle, DE; Linington, RG; Lopez, D; Sanchez, LM; Vesely, BA | 1 |
Ferreira, D; Fronczek, FR; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP | 1 |
Guerrant, W; Gurard-Levin, ZA; Khan, SI; Mrksich, M; Mwakwari, SC; Oyelere, AK; Patil, V; Tekwani, BL | 1 |
Baumann, K; Bischof, SK; Bringmann, G; Brun, R; Dreher, J; Gulder, T; Kaiser, M; Moll, H; Müller, S; Stich, A; Winter, C | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Singh, PP; Singh, S; Tekwani, BL | 2 |
Carvalho, L; Castanys, S; Gamarro, F; Manzano, JI; Pérez-Victoria, JM | 1 |
Anklin, C; Bahar, M; Deng, Y; Doskotch, RW; Drew, ME; Gil, RR; He, S; Kinghorn, AD; Navarro-Vázquez, A; Pandharkar, T; Werbovetz, KA; Zhu, X | 1 |
Aldana, I; Barea, C; Castillo, D; Deharo, E; Galiano, S; Monge, A; Pabón, A; Pérez-Silanes, S; Quiliano, M; Zimic, M | 1 |
Duke, SO; Ferreira, D; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP; Tekwani, BL | 1 |
Azas, N; Casanova, M; Castera-Ducros, C; Dumètre, A; Hutter, S; Kraiem-M'rabet, M; Laget, M; Mbatchi, L; Paloque, L; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cutler, HG; Cutler, SJ; Dugan, FM; Gao, J; Hill, RA; Jacob, MR; Khan, SI; León, F; Lupien, S; Radwan, MM; Tekwani, BL; Wang, X | 1 |
Agarwal, H; Bahar, M; Brun, R; Cason, E; Doskotch, RW; Drew, ME; Endeshaw, M; He, S; Kaiser, M; Kinghorn, AD; Li, C; Mahasenan, KV; Munde, M; Pandharkar, T; Werbovetz, KA; Wilson, WD; Zhu, X | 1 |
Gehrke, SS; Hider, RC; Pinto, EG; Pleban, K; Steverding, D; Tempone, AG; Wagner, GK | 1 |
Buisson, D; Fromentin, Y; Gaboriaud-Kolar, N; Grellier, P; Lallemand, MC; Lenta, BN; Loiseau, PM; Michel, S; Mouray, E; Wansi, JD | 1 |
Arafa, RK; Boykin, DW; Brun, R; Ismail, MA; Jones, SK; Pandharkar, T; Patrick, DA; Tidwell, RR; Wenzler, T; Werbovetz, KA; Zhu, X | 1 |
Batchu, H; Batra, S; Mishra, A; Shukla, PK; Singh, P; Srivastava, K | 1 |
Boykin, DW; Brun, R; Liu, ZY; Wenzler, T; Zhu, X | 1 |
Ayong, L; Bae, MA; Cechetto, J; Freitas-Junior, LH; Lee, E; Lee, HG; Lee, N; Lee, S; Lim, D; Liuzzi, M; Oh, S; Park, SB; Song, JS | 1 |
Azas, N; Bouhlel, A; Cohen, A; Curti, C; Hutter, S; Primas, N; Remusat, V; Tabélé, C; Terme, T; Vanelle, P | 1 |
Barteselli, A; Basilico, N; Boido, V; Casagrande, M; Parapini, S; Rusconi, CM; Sparatore, A; Sparatore, F; Taramelli, D; Tonelli, M | 1 |
Chibale, K; D'hooghe, M; Danneels, B; de Kock, C; Desmet, T; Smith, PJ; Van Herreweghe, S; Vandekerckhove, S; Willems, J | 1 |
Chabot, GG; Deguin, B; Dumontet, V; Espindola, LS; Grellier, P; Grougnet, R; Mai, LH; Michel, S; Poulain, C; Quentin, L; Vo, HT | 1 |
Abonia, R; Becerra, D; Cobo, J; Echeverry, C; Insuasty, B; Muñoz, JA; Nogueras, M; Ospina, V; Quiroga, J; Ramírez, J; Robledo, SM; Upegui, Y; Vélez, ID | 1 |
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Amata, E; Devine, W; Erath, J; Lee, PJ; Leed, SE; Mensa-Wilmot, K; Patel, G; Pollastri, MP; Rodriguez, A; Roncal, NE; Sciotti, RJ; Swaminathan, U; Woodring, JL | 1 |
Bosc, D; Cojean, S; Dubois, J; Franco, CH; Freitas-Junior, LH; Grellier, P; Loiseau, PM; Moraes, CB; Mouray, E | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Clark, AM; Khan, SI; Kwong, CD; Secrist, JA; Taghavi-Moghadam, S | 1 |
Aldana, I; Barea, C; Deharo, E; Galiano, S; Pabón, A; Quiliano, M; Ramirez-Calderon, G | 1 |
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK | 1 |
Amata, E; Behera, R; Erath, J; Guyett, P; Leed, SE; Mensa-Wilmot, K; Patel, G; Penn, E; Pollastri, MP; Rodriguez, A; Roncal, N; Sciotti, RJ; Sharma, A; Singh, B; Wiedeman, J; Woodring, JL | 1 |
Awori, RM; Bode, HB; Groß, J; Kaiser, M; Opatz, T; Zhao, L | 1 |
Bourdy, G; Bourgeade-Delmas, S; Castillo, D; Castro, I; Fabre, N; Gandini, C; Jullian, V; Saffon, N; Sauvain, M | 1 |
Cojean, S; Ferrié, L; Figadère, B; Le Pape, P; Loiseau, PM; Maciuk, A; Nguyen, LT; Pinet, A; Vásquez-Ocmín, P | 1 |
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
Basilico, N; Conti, P; Coser, C; Galbiati, A; Parapini, S; Tamborini, L; Taramelli, D; Zana, A | 1 |
Fossati, C | 1 |
Bartlett, MS; Eichholtz, R; Smith, JW | 1 |
Berry, CZ; Goldberg, LC; Shepard, WL | 1 |
Duma, RJ; Markowitz, SM; Martinez, AJ; Shiel, FO | 1 |
Lapierre, J | 1 |
Bryceson, AD | 1 |
Goltz, RW; Hart, M; Livingood, CS; Totonchy, M | 1 |
Crommelin, DJ; Storm, G; Vingerhoeds, MH | 1 |
Mak, JW; Radzan, T; Rain, AN; Sajiri, S | 1 |
Suzuki, M | 1 |
Bhasin, VK; Bhattacharya, A; Mishra, LC | 1 |
Azas, N; Dumètre, A; Gellis, A; Hutter, S; Lanzada, G; Ollivier, E; Vanelle, P | 1 |
Croft, SL; Murdan, S; Van Bocxlaer, K; Wijnant, GJ; Yardley, V | 1 |
4 review(s) available for chloroquine and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of intestinal parasitosis].
Topics: Amphotericin B; Anthelmintics; Bithionol; Cestode Infections; Chloroquine; Humans; Intestinal Diseases, Parasitic; Leishmaniasis; Malaria; Metronidazole; Nematode Infections; Quinacrine; Tetracycline; Thiabendazole | 1975 |
Immunoliposomes in vivo.
Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Biological Availability; Candidiasis; Chloroquine; Clinical Trials as Topic; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Humans; Immunoconjugates; Injections, Intravenous; Liposomes; Lung; Lymph Nodes; Malaria; Mice; Neoplasms; Peritoneal Cavity; Plasmodium berghei; Rats; Tissue Distribution | 1994 |
[Neurological toxicity of antifungal and antiprotozoal drugs].
Topics: Amphotericin B; Antifungal Agents; Antimalarials; Antiprotozoal Agents; Antitrichomonal Agents; Central Nervous System Diseases; Chloroquine; Humans; Mefloquine; Metronidazole; Quinine | 1999 |
92 other study(ies) available for chloroquine and amphotericin b
Article | Year |
---|---|
New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica.
Topics: Anti-HIV Agents; Antifungal Agents; Antimalarials; Flavonoids; Lignans; Magnetic Resonance Spectroscopy; Plants, Medicinal | 1997 |
Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): influence of the linker.
Topics: Acridines; Animals; Antimalarials; Cell Line; Leishmania infantum; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2000 |
Antimalarial, cytotoxic, and antifungal alkaloids from Duguetia hadrantha.
Topics: Alkaloids; Animals; Antifungal Agents; Antimalarials; Antineoplastic Agents, Phytogenic; Brazil; Cell Adhesion; Cell Aggregation; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Paraguay; Plant Extracts; Plants, Medicinal; Plasmodium falciparum; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 2001 |
Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Benzopyrans; Benzoxazines; Cannabinoids; Cells, Cultured; Chloroquine; Cryptococcus neoformans; Drug Resistance, Microbial; Fabaceae; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methicillin; Molecular Conformation; Molecular Structure; Morpholines; Naphthalenes; Peru; Plant Stems; Plants, Medicinal; Plasmodium falciparum; Sesquiterpenes; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Structure-Activity Relationship; Tetracycline | 2001 |
Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshinones.
Topics: Abietanes; Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Chromatography, Thin Layer; Diterpenes; Drug Resistance; Humans; Iran; Lamiaceae; Leishmania major; Lymphocytes; Nuclear Magnetic Resonance, Biomolecular; Phenanthrenes; Phytohemagglutinins; Plant Lectins; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2001 |
Leishmanicidal and antiplasmodial activity of constituents of Smirnowia iranica.
Topics: Animals; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Cyclohexenes; Erythrocytes; Fabaceae; Inhibitory Concentration 50; Iran; Isoflavones; Leishmania; Macrophages; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenylpropionates; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship | 2002 |
Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum.
Topics: Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Benzopyrans; Candida albicans; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Staphylococcus aureus; Stereoisomerism | 2003 |
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge.
Topics: Alkaloids; Animals; Anti-HIV Agents; Antiprotozoal Agents; Carbazoles; Carbolines; Crystallography, X-Ray; Indoles; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nucleosides; Porifera; Pyrroles; Stereoisomerism | 2003 |
Antiparasitic alkaloids from Psychotria klugii.
Topics: Alkaloids; Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plants, Medicinal; Plasmodium falciparum; Psychotria; Quinazolines; Tumor Cells, Cultured | 2003 |
Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Artemisinins; Clone Cells; Drug Design; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Leishmania donovani; Malaria, Falciparum; Models, Molecular; Molecular Conformation; Plasmodium falciparum; Sesquiterpenes; Static Electricity; Stereoisomerism; Structure-Activity Relationship | 2003 |
A new antimalarial quassinoid from Simaba orinocensis.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Peru; Plants, Medicinal; Plasmodium falciparum; Quassins; Simaroubaceae; Tumor Cells, Cultured | 2004 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
Topics: Animals; Antimalarials; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Databases, Factual; Leishmania donovani; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Trypanocidal Agents | 2004 |
Bisnortriterpenes from Salacia madagascariensis.
Topics: Animals; Celastraceae; Leishmania; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Plants, Medicinal; Tanzania; Triterpenes | 2005 |
New clerodane diterpenoids from Laetia procera (Poepp.) Eichler (Flacourtiaceae), with antiplasmodial and antileishmanial activities.
Topics: Animals; Antimalarials; Cell Line, Tumor; Diterpenes; Diterpenes, Clerodane; Humans; Inhibitory Concentration 50; Leishmania; Magnetic Resonance Spectroscopy; Magnolia; Molecular Structure; Plasmodium falciparum; Structure-Activity Relationship | 2005 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Epithelial Cells; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Phloroglucinol; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiparasitic Agents; Bacteria; Chlorocebus aethiops; Erythrocytes; Fungi; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Leishmania donovani; Magnetic Resonance Spectroscopy; Methemoglobin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Bacteria; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Fungi; Humans; Indicators and Reagents; Indole Alkaloids; Indoles; Isomerism; Leishmania donovani; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vero Cells | 2007 |
Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro.
Topics: Acridines; Animals; Antiparasitic Agents; Combinatorial Chemistry Techniques; Eukaryota; HL-60 Cells; Humans; Parasitic Sensitivity Tests; Plasmodium falciparum; Polyamines; Schistosoma mansoni; Structure-Activity Relationship; Trypanosoma brucei brucei | 2007 |
Synthesis of isoquinuclidine analogs of chloroquine: antimalarial and antileishmanial activity.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Chloroquine; Leishmania; Plasmodium falciparum; Quinuclidines | 2007 |
BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.
Topics: Antiviral Agents; BK Virus; Cell Line; Chloroquine; Humans; Microbial Sensitivity Tests; Molecular Structure; Nystatin; Virus Replication | 2007 |
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Biomimetic Materials; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium avium Complex; Phloroglucinol; Plasmodium falciparum; Staphylococcus aureus; Structure-Activity Relationship; Terpenes | 2008 |
Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines.
Topics: Animals; Antimalarials; Cell Line; Chloroquine; Drug Resistance; Humans; Hydrocarbons, Chlorinated; Plasmodium falciparum; Quinazolines | 2008 |
2-N-Methyl modifications and SAR studies of manzamine A.
Topics: Animals; Antimalarials; Carbazoles; Carbolines; Chlorocebus aethiops; Erythrocytes; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Kidney; Methylation; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2008 |
Kinetic studies and bioactivity of potential manzamine prodrugs.
Topics: Administration, Oral; Animals; Antimalarials; Candida albicans; Carbolines; Chlorocebus aethiops; Cryptococcus neoformans; Disease Models, Animal; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Prodrugs; Vero Cells | 2008 |
Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis.
Topics: Animals; Antiprotozoal Agents; Cyanobacteria; Depsipeptides; Leishmania mexicana; Marine Biology; Molecular Structure; Panama; Plasmodium falciparum; Trypanosoma cruzi | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Antileishmanial constituents of the Panamanian endophytic fungus Edenia sp.
Topics: Animals; Antiprotozoal Agents; Ascomycota; Heterocyclic Compounds, 4 or More Rings; Leishmania donovani; Molecular Structure; Naphthalenes; Nuclear Magnetic Resonance, Biomolecular; Panama; Plasmodium falciparum; Spiro Compounds | 2008 |
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Topics: Angiogenesis Inhibitors; Animals; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Humans; Leishmania; Mice; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis | 2009 |
Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A.
Topics: Animals; Antimalarials; Antimicrobial Cationic Peptides; Caribbean Region; Chloroquine; Cyanobacteria; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Parasitic Sensitivity Tests; Peptides; Plasmodium falciparum | 2009 |
Biologically active cannabinoids from high-potency Cannabis sativa.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Aspergillus fumigatus; Candida; Cannabinoids; Cannabis; Chlorocebus aethiops; Escherichia coli; Gas Chromatography-Mass Spectrometry; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Plasmodium falciparum; Pseudomonas aeruginosa | 2009 |
Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines.
Topics: Aniline Compounds; Animals; Antimalarials; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leishmania donovani; Plasmodium falciparum; Quinazolines; Structure-Activity Relationship; Toxoplasma | 2009 |
Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates.
Topics: Animals; Anti-HIV Agents; Antiparasitic Agents; Heterocyclic Compounds, 3-Ring; Humans; Leishmania donovani; Monocytes; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolones; Trichomonas vaginalis | 2009 |
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety.
Topics: Administration, Oral; Amides; Animals; Antimalarials; Carbazoles; Carbolines; Male; Mice; Mycobacterium avium Complex; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2009 |
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization | 2009 |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
Topics: Antimalarials; Antiprotozoal Agents; Histone Deacetylase Inhibitors; Histone Deacetylases; Leishmania donovani; Leishmaniasis; Malaria; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2010 |
Synthesis and antiprotozoal activity of 4-arylcoumarins.
Topics: 4-Hydroxycoumarins; Amphotericin B; Antiprotozoal Agents; Cell Line; Cell Proliferation; Coumarins; Humans; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Palladium; Plasmodium falciparum | 2010 |
Original quinazoline derivatives displaying antiplasmodial properties.
Topics: Aniline Compounds; Animals; Antiprotozoal Agents; Cell Line; Drug Design; Humans; Inhibitory Concentration 50; Leishmania donovani; Phosphotransferases; Plasmodium falciparum; Quinazolines; Toxoplasma | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship | 2010 |
Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity.
Topics: Animals; Antiprotozoal Agents; Chloroquine; Drug Resistance; Inhibitory Concentration 50; Leishmania donovani; Lyngbya Toxins; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oligopeptides; Parasitic Sensitivity Tests; Plasmodium falciparum | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds.
Topics: Antiprotozoal Agents; Cyanobacteria; Leishmania donovani; Lipopeptides; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 2010 |
Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum.
Topics: Alkaloids; Animals; Antimalarials; Ascomycota; Chlorocebus aethiops; Chloroquine; Crystallography, X-Ray; Methicillin-Resistant Staphylococcus aureus; Molecular Conformation; Molecular Structure; Plasmodium falciparum; Pyridones | 2010 |
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Isoenzymes; Ketolides; Leishmania donovani; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents | 2010 |
QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloids.
Topics: Alkaloids; Animals; Antimalarials; Isoquinolines; Magnetic Resonance Spectroscopy; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared | 2010 |
Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines).
Topics: Aminoquinolines; Animals; Anti-Infective Agents; Antiprotozoal Agents; Hemeproteins; Humans; Methemoglobin | 2011 |
Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.
Topics: Adenosine Triphosphate; Aminoquinolines; Antiprotozoal Agents; Drug Resistance; Glycolysis; Leishmania major; Pyruvate Kinase | 2011 |
Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Topics: Animals; Antiprotozoal Agents; Berberine; Chlorocebus aethiops; Disease Models, Animal; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Malaria; Mice; Models, Molecular; Parasites; Plasmodium falciparum; Protozoan Infections; Trypanosoma brucei brucei; Trypanosomiasis; Vero Cells | 2011 |
New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.
Topics: Animals; Antimalarials; Leishmania mexicana; Macrophages; Mice; Plasmodium falciparum; Quinoxalines; Salicylamides; Structure-Activity Relationship; Sulfonamides; Trypanocidal Agents | 2011 |
Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities.
Topics: Amino Acids; Aminoquinolines; Animals; Anti-Infective Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Dipeptides; Fungi; Hemeproteins; Leishmania donovani; Mice; Peptidomimetics; Plasmodium falciparum; Vero Cells | 2012 |
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Candida glabrata; Chlorocebus aethiops; Chloroquine; Cryptococcus neoformans; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Staphylococcus aureus; Vero Cells | 2012 |
Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Hep G2 Cells; Humans; Leishmania donovani; Life Cycle Stages; Mice; Nitroquinolines | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.
Topics: | 2012 |
8,8-dialkyldihydroberberines with potent antiprotozoal activity.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Berberine Alkaloids; Crystallography, X-Ray; Female; Inhibitory Concentration 50; Leishmania donovani; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma | 2013 |
Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators.
Topics: Aminoquinolines; Antiprotozoal Agents; Deferiprone; Dose-Response Relationship, Drug; Iron Chelating Agents; Leishmania infantum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridones; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Topics: Antiprotozoal Agents; Benzophenones; Clusiaceae; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Seeds; Structure-Activity Relationship; Trypanosoma brucei brucei | 2013 |
Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives.
Topics: Animals; Antiprotozoal Agents; Benzene; Chagas Disease; Female; Leishmania donovani; Mice; Mice, Inbred Strains; Models, Chemical; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Structure-Activity Relationship; Terphenyl Compounds; Trypanosoma cruzi | 2013 |
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Ethers; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2014 |
Synthesis and antiparasitic activity of new bis-arylimidamides: DB766 analogs modified in the terminal groups.
Topics: Amides; Animals; Antiparasitic Agents; Cell Line; Chemistry Techniques, Synthetic; Leishmania; Plasmodium falciparum; Rats; Trypanosoma | 2014 |
Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
Topics: Animals; Antimalarials; Area Under Curve; Cell Line, Tumor; Cell Survival; Drug Discovery; Drug Evaluation, Preclinical; Hep G2 Cells; Host-Parasite Interactions; Humans; Life Cycle Stages; Malaria; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Models, Chemical; Molecular Structure; Plasmodium chabaudi; Plasmodium falciparum; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2014 |
New series of monoamidoxime derivatives displaying versatile antiparasitic activity.
Topics: Antiparasitic Agents; Carbon-13 Magnetic Resonance Spectroscopy; Inhibitory Concentration 50; Oximes; Spectrometry, Mass, Electrospray Ionization | 2014 |
Clofazimine analogs with antileishmanial and antiplasmodial activity.
Topics: Anti-Inflammatory Agents; Antimalarials; Antiprotozoal Agents; Cell Line; Clofazimine; Endothelial Cells; Humans; Leishmania; Plasmodium falciparum | 2015 |
Synthesis of functionalized 3-, 5-, 6- and 8-aminoquinolines via intermediate (3-pyrrolin-1-yl)- and (2-oxopyrrolidin-1-yl)quinolines and evaluation of their antiplasmodial and antifungal activity.
Topics: Aminoquinolines; Antifungal Agents; Antimalarials; Aspergillus flavus; Dose-Response Relationship, Drug; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodotorula; Structure-Activity Relationship | 2015 |
Antivascular and anti-parasite activities of natural and hemisynthetic flavonoids from New Caledonian Gardenia species (Rubiaceae).
Topics: Angiogenesis Inhibitors; Animals; Antiparasitic Agents; Cell Line, Tumor; Cell Survival; Drug Design; Flavonoids; Flowers; Gardenia; Humans; Leishmania; Molecular Structure; New Caledonia; Plant Extracts; Plasmodium falciparum; Structure-Activity Relationship; Trypanosoma brucei gambiense | 2015 |
An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents.
Topics: Antimalarials; Azepines; Caffeine; Chalcones; Chemistry Techniques, Synthetic; Humans; Inhibitory Concentration 50; Leishmania; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi; U937 Cells | 2015 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Growth Inhibitors; Hep G2 Cells; Humans; Parasites; Quinazolines | 2015 |
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
Topics: Alkyl and Aryl Transferases; Animals; Antiparasitic Agents; Cell Line; Enzyme Inhibitors; Humans; Imidazoles; Leishmania donovani; Leishmaniasis, Visceral; Malaria, Falciparum; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis | 2016 |
The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Aspergillus fumigatus; Candida albicans; Cell Line, Tumor; Chlorocebus aethiops; Cryptococcus neoformans; DNA Topoisomerases, Type I; Humans; Indenes; Naphthyridines; Plasmodium falciparum; Structure-Activity Relationship; Topoisomerase I Inhibitors; Vero Cells | 2016 |
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Topics: Antiprotozoal Agents; Humans; Hydrazines; Leishmania infantum; Leishmaniasis, Visceral; Malaria, Falciparum; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2017 |
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen | 2018 |
Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation.
Topics: | 2018 |
Structure, Biosynthesis, and Bioactivity of Photoditritide from
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Microbial Sensitivity Tests; Micrococcus luteus; Molecular Structure; Photorhabdus; Spectrum Analysis; Trypanosoma brucei rhodesiense | 2019 |
Structural Characterization and Anti-infective Activity of 9,10-Seco-29-norcycloartane Glycosides Isolated from the Flowers of the Peruvian Medicinal Plant
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Cordia; Crystallography, X-Ray; Flowers; Glycosides; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Plasmodium falciparum; RAW 264.7 Cells; Spectrum Analysis | 2019 |
Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes.
Topics: Antifungal Agents; Antiprotozoal Agents; Aspergillus; Candida; Dioxolanes; Dose-Response Relationship, Drug; Leishmania; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium; Structure-Activity Relationship | 2021 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds.
Topics: | 2021 |
Antimicrobial susceptibility of Pneumocystis carinii in culture.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Cell Line; Chloroquine; Culture Media; Drug Combinations; Humans; Metronidazole; Miconazole; Pentamidine; Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Systemic lupus erythematosus complicated by coccidioidomycosis.
Topics: Adrenocorticotropic Hormone; Adult; Amphotericin B; Chloroquine; Coccidioidomycosis; Cortisone; Female; Humans; Lupus Erythematosus, Systemic; Methoxsalen; Methylprednisolone; Prednisolone; Tetracycline | 1968 |
Myocarditis associated with primary amebic (Naegleria) meningoencephalitis.
Topics: Adolescent; Adult; Amoeba; Amphotericin B; Brain; Bronchopneumonia; Child; Chloroquine; Electrocardiography; Emetine; Eosinophils; Exudates and Transudates; Female; Hepatitis; Humans; Male; Meningoencephalitis; Metronidazole; Myocarditis; Myocardium; Penicillins; Pulmonary Edema; Sulfadiazine; Sulfisoxazole | 1974 |
[Leishmaniasis].
Topics: Amidines; Amphotericin B; Anemia; Animals; Antimony; Blood Protein Electrophoresis; Child, Preschool; Chloroquine; Complement Fixation Tests; Diagnosis, Differential; Dogs; Haplorhini; Hepatomegaly; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Leukopenia; Liver Function Tests; Metronidazole; Rodentia; Skin Tests; Splenomegaly | 1969 |
Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.
Topics: Adolescent; Amidines; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Chloroquine; Female; Gluconates; Griseofulvin; Humans; Immunity; Leishmaniasis; Primaquine; Proguanil; Sulfonic Acids | 1970 |
Late cutaneous leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Biopsy; Chloroquine; Humans; Injections, Intradermal; Leishmania; Leishmaniasis; Male; Skin Diseases, Infectious | 1969 |
In vitro drug susceptibility of Acanthamoeba castellani to chloroquine, ivermectin and fungizon.
Topics: Acanthamoeba; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Ivermectin; Time Factors | 1996 |
In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum.
Topics: Amphotericin B; Animals; Antimalarials; Artemisinins; Chloroquine; Clotrimazole; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Hot Temperature; Plasmodium falciparum | 2008 |
Preparation and antiprotozoal evaluation of promising β-carboline alkaloids.
Topics: Alkaloids; Amphotericin B; Antiprotozoal Agents; Carbolines; Chloroquine; Doxycycline; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Leishmania donovani; Pentamidine; Plasmodium falciparum; Structure-Activity Relationship | 2012 |
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chloroquine; Disease Models, Animal; Drug Combinations; Female; Leishmania major; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Parasite Load; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2017 |